| 2024-06-12 | Sale | Ultragenyx Pharmaceutical Inc. RARE | EVP and Chief Legal Officer | 9,806 0.0128% | $45.00 | $441,270 | -11.49% | |
| 2024-03-01 | Sale | Ultragenyx Pharmaceutical Inc. RARE | EVP and Chief Legal Officer | 3,756 0.0046% | $53.76 | $201,923 | -19.54% | |
| 2024-01-30 | Sale | Evolus, Inc. EOLS | director | 11,931 0.0211% | $13.14 | $156,733 | +2.33% | |
| 2023-05-04 | Sale | Ultragenyx Pharmaceutical Inc. RARE | EVP and Chief Legal Officer | 4,378 0.0061% | $45.00 | $197,010 | -3.6% | |
| 2023-03-01 | Sale | Ultragenyx Pharmaceutical Inc. RARE | EVP and Chief Legal Officer | 3,161 0.0045% | $45.25 | $143,035 | -7.47% | |
| 2022-03-07 | Sale | Ultragenyx Pharmaceutical Inc. RARE | EVP and Chief Legal Officer | 5,140 0.0074% | $62.95 | $323,563 | -24.95% | |
| 2022-03-01 | Sale | Ultragenyx Pharmaceutical Inc. RARE | EVP and Chief Legal Officer | 2,886 0.0041% | $66.62 | $192,265 | -29.29% | |
| 2021-10-14 | Sale | Ultragenyx Pharmaceutical Inc. RARE | EVP and General Counsel | 310 0.0005% | $81.14 | $25,153 | -17.23% | |
| 2021-09-08 | Sale | Ultragenyx Pharmaceutical Inc. RARE | EVP and General Counsel | 7,336 0.0106% | $100.65 | $738,368 | -31.73% | |
| 2021-06-10 | Sale | Ultragenyx Pharmaceutical Inc. RARE | EVP and General Counsel | 1,329 0.002% | $100.00 | $132,900 | -19.8% | |
| 2021-05-06 | Sale | Ultragenyx Pharmaceutical Inc. RARE | EVP and General Counsel | 313 0.0005% | $113.67 | $35,579 | -29.17% | |
| 2021-03-01 | Sale | Ultragenyx Pharmaceutical Inc. RARE | EVP and General Counsel | 3,970 0.0057% | $138.17 | $548,535 | -38.37% | |
| 2020-10-30 | Sale | Ultragenyx Pharmaceutical Inc. RARE | EVP and General Counsel | 9,903 0.0153% | $100.12 | $991,488 | +6.18% | |
| 2020-10-28 | Sale | Ultragenyx Pharmaceutical Inc. RARE | EVP and General Counsel | 97 0.0002% | $100.00 | $9,700 | +12.26% | |
| 2020-10-14 | Sale | Ultragenyx Pharmaceutical Inc. RARE | EVP and General Counsel | 325 0.0005% | $88.00 | $28,600 | +15.06% | |
| 2020-10-08 | Sale | Ultragenyx Pharmaceutical Inc. RARE | EVP and General Counsel | 10,000 0.0156% | $95.00 | $950,000 | +12.94% | |
| 2020-10-06 | Sale | Ultragenyx Pharmaceutical Inc. RARE | EVP and General Counsel | 10,000 0.0157% | $90.00 | $900,000 | +19.98% | |
| 2020-09-23 | Sale | Ultragenyx Pharmaceutical Inc. RARE | EVP and General Counsel | 10,000 0.0169% | $85.00 | $850,000 | +28.9% | |
| 2020-08-17 | Sale | Ultragenyx Pharmaceutical Inc. RARE | EVP and General Counsel | 12,370 0.0206% | $88.43 | $1.09M | +21.8% | |
| 2020-05-18 | Sale | Ultragenyx Pharmaceutical Inc. RARE | EVP and General Counsel | 2,722 0.0047% | $74.72 | $203,374 | +46.65% |